Safety and Immunogenicity of Seasonal Influenza Vaccine With Topical Imiquimod in Immunocompromised Patients: A Randomized Controlled Pilot Trial
Latest Information Update: 01 Aug 2021
At a glance
- Drugs Imiquimod (Primary) ; Influenza virus vaccine (Primary) ; Influenza virus vaccine (Primary)
- Indications Immunocompromised infections; Influenza virus infections
- Focus Pharmacodynamics
- Acronyms IMIFLU
- 20 Jul 2021 Primary endpoint (Response to the vaccine) has not been met. according to the results published in the Journal of Infection.
- 20 Jul 2021 Results published in the Journal of Infection.
- 09 Oct 2017 Status changed from recruiting to completed.